The average one-year price target for Core Laboratories (NYSE:CLB) has been revised to $15.64 / share. This is an increase of 11.51% from the prior estimate of $14.02 dated September 27, 2025. The ...
(1) Three months ended September 30, 2024 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share ...
Hosted on MSN
Core Laboratories outlines Q3 2025 revenue guidance of $127.5M-$134.5M amid margin improvements and global expansion
CEO Lawrence V. Bruno highlighted that "Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic ...
Hosted on MSN
Core Laboratories projects Q4 2025 revenue of $132M–$136M as international demand drives growth
Gwendolyn Schreffler, Senior Vice President, projected Core's fourth quarter 2025 revenue to range from $132 million to $136 million with operating income of $14 million to $16.1 million and operating ...
HOUSTON, July 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported second quarter 2025 revenue of ...
HOUSTON (AP) — HOUSTON (AP) — Core Laboratories Inc. (CLB) on Wednesday reported second-quarter net income of $10.6 million. The Houston-based company said it had profit of 22 cents per share.
Core Laboratories’ core analysis services in particular are a key element of oil and gas development, directly informing further reservoir analysis (seismic, wireline logging, and so on) that’s ...
probability of performance condition for certain executive's share awards. (2) Three months ended June 30, 2025 and September 30, 2025 includes the write-down of inventory. (3) Three months ended June ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback